Virtual Medicinal Product (VMP) - Insulin lispro biphasic 25/75 100units/ml suspension for injection 3ml cartridges

Navigation

Name Details

Name Start Date End Date
Name Current Name Insulin lispro biphasic 25/75 100units/ml suspension for injection 3ml cartridges Start Date 11-10-2004 End Date
Previous Name Previous Name Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml suspension for injection 3ml cartridges Start Date 25-06-2004 End Date 10-10-2004

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
3
UDFS UOM
ml
Unit Dose UOM
cartridge

Summary

Prescribing Status
Caution - AMP level prescribing advised
Controlled Drug Category
No Controlled Drug Status
Route
Subcutaneous
Form
Suspension for injection
Ontology Form/Route
suspensioninjection.subcutaneous
Name Basis
Other

Codes

ATC Code
A10AD04
BNF Start Date End Date
Current BNF 06010102 Start Date 04-04-2022 End Date
Previous BNF 06010102 Start Date 01-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
3473711000001102 17-12-2002

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Insulin lispro Based on Ingredient Substance 25 unit 1 ml
Insulin lispro protamine Based on Base Substance Insulin lispro 75 unit 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
5 cartridge 2946 Part VIIIA Category C